Insider · CIK 0002119332

Kemula Pierre Thadee Victor

Reports to the SEC for 1 company · ANTWERPEN

Transactions

Companies

Filings

CIK

0002119332

Forms 4 and 5

Insider transactions

3 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-06	AGMBAgomAb Therapeutics NVP Purchase	Chief Financial Officer	PPurchase	+3,000 sh	$8.67	+$26K	3,000
2026-10-06	AGMBAgomAb Therapeutics NVP Purchase	Chief Financial Officer	PPurchase	+5,000 sh	$8.57	+$42.9K	8,000
2026-10-06	AGMBAgomAb Therapeutics NVP Purchase	Chief Financial Officer	PPurchase	+2,000 sh	$8.54	+$17.1K	10,000

C/O AGOMAB THERAPEUTICS NV POSTHOFLEI 1/6 2600

ANTWERPEN, 00000